2834 – Page 12 – China Stock Advice

CPHI [CHINA PHARMA] 8-K: (Original Filing)

[]

By info| 2018-12-07T04:37:07+00:00 December 6th, 2018|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 2018-12-06, 2834, 8-K, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMA] 8-K:

[]

By info| 2018-12-07T04:37:11+00:00 December 6th, 2018|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 2018-12-06, 2834, 8-K, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Hong Kong High Court Issues Declaratory Orders and Permanent Injunctive Relief in Favor of Sinovac’s Biotech Ltd. Senior Management Permanent Injunction Restrains Mr. Li and Mr. Cao from Purporting to Act as or Take Any Actions as Directors of Sinovac HK or its subsidiaries BEIJING, Nov. 28, 2018— S]

By info| 2018-11-29T04:31:57+00:00 November 28th, 2018|Categories: Chinese Stocks, SEC Original, SVA|Tags: 0001084201, 2018-11-28, 2834, 6-K, PHARMACEUTICAL PREPARATIONS, SVA|0 Comments

SVA [SINOVAC BIOTECH] 6-K: Hong Kong High Court Issues Declaratory Orders and

[Hong Kong High Court Issues Declaratory Orders and Permanent Injunctive Relief in Favor of Sinovac’s Biotech Ltd. Senior Management Permanent Injunction Restrains Mr. Li and Mr. Cao from Purporting to Act as or Take Any Actions as Directors of Sinovac HK or its subsidiaries BEIJING, Nov. 28, 2018— S]

By info| 2018-11-29T04:32:02+00:00 November 28th, 2018|Categories: Chinese Stocks, SVA, Webplus ver|Tags: 0001084201, 2018-11-28, 2834, 6-K, PHARMACEUTICAL PREPARATIONS, SVA|0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Reports Unaudited First Half of 2018 Financial Results BEIJING, China, November 8, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six mont]

By info| 2018-11-09T04:55:47+00:00 November 8th, 2018|Categories: Chinese Stocks, SEC Original, SVA|Tags: 0001084201, 2018-11-08, 2834, 6-K, PHARMACEUTICAL PREPARATIONS, SVA|0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited First Half of 2018 Financial

[Sinovac Reports Unaudited First Half of 2018 Financial Results BEIJING, China, November 8, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six mont]

By info| 2018-11-09T04:55:54+00:00 November 8th, 2018|Categories: Chinese Stocks, SVA, Webplus ver|Tags: 0001084201, 2018-11-08, 2834, 6-K, PHARMACEUTICAL PREPARATIONS, SVA|0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Reports Unaudited First Half of 2018 Financial Results BEIJING, China, November 8, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six mont]

By info| 2018-11-08T13:04:23+00:00 November 8th, 2018|Categories: Chinese Stocks, SEC Original, SVA|Tags: 0001084201, 2018-11-08, 2834, 6-K, PHARMACEUTICAL PREPARATIONS, SVA|0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited First Half of 2018 Financial

[Sinovac Reports Unaudited First Half of 2018 Financial Results BEIJING, China, November 8, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six mont]